TERADYNE, INC TER revenue by segment, product and geography
In its fiscal year ending 2025-12-31, TERADYNE, INC reported revenue across 1 business segments; the largest, Product Test, was $358M, 100.0% of the filed sum (+8.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product Test$358M100.0%+8.1% yoy
Members sum to $358M against $3.19B consolidated (residual $2.83B) - eliminations or corporate lines the filer did not tag on this axis.
- Product$2.66B83.4%+15.9% yoy
- Service$530M16.6%+0.9% yoy
Members sum to the consolidated $3.19B for this period.
- Asia Pacific$2.54Bshare n/a+19.4% yoy
- Taiwan$1.16Bshare n/a+91.9% yoy
- China$451Mshare n/a+20.3% yoy
- South Korea$446Mshare n/a-35.8% yoy
- Americas$426Mshare n/a-2.3% yoy
- United States$361Mshare n/a-3.6% yoy
- EMEA$224Mshare n/a-12.7% yoy
- Europe$215Mshare n/a-14.3% yoy
- +6 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Product Test$107M100.0%+26.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.